Senior Leadership The Cancer Center requests support (16.2 calendar months, 1.35 FTE, $334,153) for an experienced and enhanced Senior Leadership team that includes Shelton Earp, MD (Director) and eight Associate Directors, including: Albert Baldwin, PhD (Basic Sciences), William Marzluff, PhD (Basic Science Cores), Richard Goldberg, MD (Clinical Research);Lisa Carey, MD (Clinical Science), Ned Sharpless MD (Translational Science);Tom Shea (Clinical Outreach), Andy Olshan (Population Sciences), and Michael O'Malley, PhD (Administration and Planning). The team has been strengthened by the addition of Drs. Carey, Sharpless, Shea, and Olshan. These new leaders join a stable group, almost all of whom have been with the Center for more than 15 years. The Director and Senior Leaders interact frequently. In addition to multiple individual interactions, the Senior Leadership team meets weekly with the Director. Senior Leaders are members of the Center's Program Planning Committee, which meets monthly. They are also active participants in their respective research programs and interact scientifically with the Program Leaders and program members. They interact with the Center's visitors, meeting individually, for example, with most of the seminar speakers to discuss the Center's development. Senior (and Program) Leaders are intimately involved in recruiting, serving as chairs or members of all the search committees. They contribute significantly to the Center's strategic planning process and the overall planning and evaluation effort.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-38
Application #
8594110
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$271,532
Indirect Cost
$66,182
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ziehr, Benjamin; Vincent, Heather A; Moorman, Nathaniel J (2016) Human Cytomegalovirus pTRS1 and pIRS1 Antagonize Protein Kinase R To Facilitate Virus Replication. J Virol 90:3839-48
Xiao, Ping-Jie; Mitchell, Angela M; Huang, Lu et al. (2016) Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction. Hum Gene Ther 27:309-24
White, Alexandra J; Bradshaw, Patrick T; Herring, Amy H et al. (2016) Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int 89-90:185-92
Xu, Yang; Chaudhury, Arindam; Zhang, Ming et al. (2016) Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest 126:2678-88
He, Zhijian; Wan, Xiaomeng; Schulz, Anita et al. (2016) A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101:296-309
Moracco, Kathryn E; Morgan, Jennifer C; Mendel, Jennifer et al. (2016) ""My First Thought was Croutons"": Perceptions of Cigarettes and Cigarette Smoke Constituents Among Adult Smokers and Nonsmokers. Nicotine Tob Res 18:1566-74
Park, Eliza M; Deal, Allison M; Check, Devon K et al. (2016) Parenting concerns, quality of life, and psychological distress in patients with advanced cancer. Psychooncology 25:942-8
Ohkuni, Kentaro; Takahashi, Yoshimitsu; Fulp, Alyona et al. (2016) SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell :
Becker, Marc A; Ibrahim, Yasir H; Oh, Annabell S et al. (2016) Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer. PLoS One 11:e0150564
Sin, Sang-Hoon; Kang, Sun Ah; Kim, Yongbaek et al. (2016) Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. J Virol 90:2150-4

Showing the most recent 10 out of 897 publications